Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

3187

Actual shortage: 257 (8%)
Anticipated shortage: 1 (0%)
Avoided shortage: 10 (0%)
Resolved: 2919 (92%)

Discontinuation Reports

435

To be discontinued: 2 (0%)
Discontinued: 410 (94%)
Reversed: 23 (5%)

Late reports

482 (13%)

Overdue reports

11 (4%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-METFORMIN 850MG TABLET Resolved 2020-10-01 2020-10-22 125455
TEVA-METFORMIN 850MG TABLET Resolved 2023-01-19 2023-04-28 181594
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65990
ACT METHYLPHENIDATE ER 27MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65993
ACT METHYLPHENIDATE ER 36MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65996
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2018-11-01 2024-02-13 65999
ACT METHYLPHENIDATE ER 18MG TABLET (EXTENDED-RELEASE) Resolved 2024-03-28 2024-05-09 223862
ACT METHYLPHENIDATE ER 54MG TABLET (EXTENDED-RELEASE) Resolved 2024-05-16 2024-09-19 228143
ACT NABILONE 1MG CAPSULE Resolved 2019-10-17 2020-03-12 96733
ACT NABILONE 1MG CAPSULE Resolved 2019-12-19 2020-03-12 101730
ACT NABILONE 0.5MG CAPSULE Resolved 2019-12-19 2020-03-12 101740
ACT NABILONE 0.5MG CAPSULE Resolved 2020-04-16 2021-09-23 112394
ACT NABILONE 0.5MG CAPSULE Resolved 2020-07-16 2020-08-07 120459
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-03-17 2018-06-15 3357
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-06-15 10972
ACT OLANZAPINE ODT 20MG TABLET (ORALLY DISINTEGRATING) Resolved 2017-05-24 2018-10-11 10975
ACT OLANZAPINE ODT 5MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-09-05 2019-10-26 93156
ACT OLANZAPINE ODT 10MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99965
ACT OLANZAPINE ODT 15MG TABLET (ORALLY DISINTEGRATING) Resolved 2019-11-28 2020-01-24 99968
TEVA-OLMESARTAN 40MG TABLET Resolved 2018-10-22 2020-06-11 65340

Showing 181 to 200 of 3187

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-TECNAL C 1/4 330MG 50MG 15MG 40MG CAPSULE Discontinued 2019-04-11 2019-04-11 81353
TEVA-TEMOZOLOMIDE 100MG CAPSULE Discontinued 2025-05-28 2025-05-28 258603
TEVA-TEMOZOLOMIDE 20MG CAPSULE Discontinued 2025-05-28 2025-05-28 258609
TEVA-TENOFOVIR 300MG TABLET Discontinued 2025-04-29 2025-04-29 256088
TEVA-TERAZOSIN 5MG TABLET Discontinued 2025-06-17 2025-06-17 260552
TEVA-TERBINAFINE 250MG TABLET Discontinued 2025-05-28 2025-05-28 258663
TEVA-TERBINAFINE 250MG TABLET Discontinued 2025-05-28 2025-05-28 258780
TEVA-TERBINAFINE 250MG TABLET Discontinued 2025-09-02 2025-09-02 266365
TEVA-TOLTERODINE 2MG TABLET Discontinued 2025-05-28 2025-05-28 258658
TEVA-TOLTERODINE 1MG TABLET Discontinued 2025-05-28 2025-05-28 258661
TEVA-TOPILENE 0.05% LOTION Discontinued 2025-05-28 2025-05-28 258553
TEVA-TOPISONE 0.05% LOTION Discontinued 2024-06-28 2024-06-29 231589
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Discontinued 2025-04-29 2025-04-29 256104
TEVA-TOPOTECAN 4MG POWDER FOR SOLUTION Discontinued 2025-05-28 2025-05-28 258420
TEVA-TRANDOLAPRIL 0.5MG CAPSULE Discontinued 2020-07-10 2020-07-10 120021
TEVA-TRANDOLAPRIL 1MG CAPSULE Discontinued 2020-07-10 2020-07-10 120024
TEVA-TRANDOLAPRIL 2MG CAPSULE Discontinued 2020-07-10 2020-07-10 120027
TEVA-TRANDOLAPRIL 4MG CAPSULE Discontinued 2020-07-10 2020-07-10 120030
TEVA-TRAVOPROST Z OPHTHALMIC SOLUTION 0.004% SOLUTION Discontinued 2020-01-21 2020-01-21 103788
TEVA-TRIACOMB 0.25MG 2.5MG 1MG 100000UNIT CREAM Discontinued 2025-05-28 2025-05-28 258390

Showing 381 to 400 of 435